• Caspofungin and the Next Logic of Candida Translation

  2026-09-20

  Caspofungin is more than a benchmark antifungal compound: it is a mechanistic probe for fungal cell wall vulnerability, resistance biology, assay design, and delayed-treatment translation. This article connects glucan synthase inhibition with decision-making strategies for researchers studying resistant Candida, including Candida auris.

• Promethazine HCl: Macrophage Assay Workflows

  2026-09-19

  Promethazine HCl can connect histamine-receptor pharmacology with macrophage-centered studies of ROS, autophagy, and intracellular bacterial control. This workflow-focused guide covers stock preparation, assay design, orthogonal validation, troubleshooting, and the limits of translating class-level phenothiazine findings to a specific compound.

• Plk1 Control of p31comet in Mitotic Checkpoint Exit

  2026-09-18

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct inhibitor of p31comet-mediated mitotic checkpoint complex disassembly. By combining checkpoint extracts, purified proteins, kinase assays, and an S102A mutant, the authors show how Plk1 phosphorylation can prevent premature checkpoint silencing and limit futile cycles of MCC assembly and disassembly.

• Dacarbazine Workflows for Cancer Drug Response

  2026-09-18

  Build more informative Dacarbazine assays by separating growth inhibition from true cell killing across melanoma, lymphoma, and sarcoma models. This practical workflow combines controlled dosing, time-resolved viability measurements, orthogonal DNA-damage readouts, and troubleshooting for metabolism-sensitive responses.

• Penicillin G Sodium in Intestinal Barrier Assays

  2026-09-17

  Penicillin G Sodium is a natural penicillin antibiotic whose selective antibacterial action can improve experimental control without being mistaken for an anti-inflammatory treatment. This article connects its mechanism with modern intestinal barrier assays and explains how to separate contamination control from LPS-driven biology.

• Gepotidacin for Uncomplicated Urogenital Gonorrhea

  2026-09-17

  This phase 2 study evaluated gepotidacin, a first-in-class bacterial type II topoisomerase inhibitor, as a single oral treatment for uncomplicated urogenital gonorrhea. Both tested doses produced high microbiological eradication rates, while the observed failures highlighted the importance of baseline susceptibility and resistance-associated mutations.

• Coelenterazine for Reliable ROS Reporter Assays

  2026-09-16

  Learn how Coelenterazine, SKU B6010, can complement viability, proliferation, cytotoxicity, and reporter assays through controlled chemiluminescent ROS detection. This scenario-based guide covers solvent selection, assay compatibility, controls, interpretation, storage, and practical vendor evaluation.

• Difloxacin HCl: From Gyrase to MDR Strategy

  2026-09-16

  Difloxacin HCl offers translational researchers a mechanistically grounded way to connect bacterial DNA gyrase inhibition, antimicrobial susceptibility testing, and multidrug resistance reversal. This article distinguishes established evidence from workflow hypotheses and uses mitotic checkpoint research to frame a broader strategy for interpreting resistance, checkpoint control, and assay context.

• Aclacinomycin A: Mapping Topological DNA Stress

  2026-09-15

  Aclacinomycin A, or Aclarubicin, is a dual topoisomerase inhibitor and DNA damage inducer with apoptosis and proteasome-related effects. This article presents an assay-centered framework for connecting its molecular activity to persistent rDNA lesions, PML-nucleolar responses, and interpretable cancer-cell phenotypes.

• Dabigatran: Clinical and Pharmacoeconomic Evidence

  2026-09-15

  This review synthesized the early clinical and economic evidence for Dabigatran, the first commercially available oral direct thrombin inhibitor, across atrial fibrillation, venous thromboembolism, and orthopedic prophylaxis. Its main contribution was to show that reduced monitoring and fixed dosing could be clinically valuable, while renal accumulation, bleeding concerns, higher cost, and limited long-term evidence constrained interpretation.

• Apigenin Workflows for HDAC and Neuroprotection

  2026-09-14

  Build reproducible Apigenin assays around HDAC-linked apoptosis, oxidative stress, and DNA damage readouts rather than relying on viability alone. The same workflow can be adapted from malignant mesothelioma models to network-medicine-informed neuroprotection studies, with clear limits on cross-domain interpretation.

• IWR-1-endo Workflow for Wnt Signaling Studies

  2026-09-14

  IWR-1-endo provides chemically controlled inhibition of Wnt/β-catenin signaling for colorectal cancer, regeneration, and mechanism-focused cell-state studies. This practical guide connects Axin-complex stabilization with dose design, orthogonal readouts, single-nucleus profiling, and troubleshooting.

• Doxorubicin: Mitochondrial Readouts for Safer Assays

  2026-09-13

  Doxorubicin research can reveal both tumor-cell vulnerability and mitochondrial cardiotoxicity. This evidence-led guide translates the Cirsium setidens study into assay design, endpoint selection, and interpretation strategies for more informative cancer and cardiac models.

• Dacarbazine Workflows for DNA Damage Research

  2026-09-12

  Build reproducible Dacarbazine experiments around exposure control, DNA-damage readouts, and clinically relevant cancer models. This guide connects melanoma, Hodgkin lymphoma, and sarcoma research with practical assay design and a carefully bounded supportive-care perspective.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages via AMPK

  2026-09-11

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that accumulates in lysosomes of tumor-associated macrophages and activates AMPKα through a GPR155–mTORC1 mechanism. The resulting AMPK–STAT6 pathway increases ARG1 expression and macrophage-mediated immune suppression, while CH25H targeting improves T-cell activity and anti-PD-1 responses.

8594 records 1/573 page Next 12345 下5页 Last page